HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Diabetes & Endocrinology
Meta-analysis
Reversion of Prediabetes to Normoglycemia Linked to 68% Lower Diabetes Risk
Reversing prediabetes cuts diabetes risk by 68 percent in a massive study
A meta-analysis of 535,066 participants with prediabetes found that reversion to normoglycemia was associated with a 68% lower risk of incid…
Reversing prediabetes to normal blood sugar levels lowers the risk of developing diabetes by 68 percent in people with the condition.
May 1, 2026
Primary Care & Family Medicine
Sys. Review
Systematic review of observational data shows wide variation in primary care discontinuation of lipid-lowering and antihypertensive therapies
Millions of heart patients stop or restart key medicines at alarming rates in primary care
This systematic review of observational data analyzed 9,146,252 patients in primary care regarding discontinuation and restarting of lipid-l…
Nearly one million patients in primary care stopped or restarted heart medicines within a year, with rates varying widely by age and backgro…
medRxiv
Apr 29, 2026
Cardiology
Meta-analysis
Systematic review of cardiovascular disease incidence in Italian adults without baseline disease
Heart attack and stroke risks vary wildly across Italian adults over decades
This systematic review examined the incidence of fatal and non-fatal major cardiovascular events in Italian adults aged 18 to 65 years witho…
A review of nineteen studies shows heart attack and stroke rates in Italy range from 10 per thousand per year to 46.5 per thousand over 40 y…
Frontiers
Apr 29, 2026
Cardiology
Cohort
Retrospective cohort study links ABSI and TyG index to incident cardiovascular disease in Chinese adults
Combining Body Shape And Blood Sugar Predicts Heart Risk Better
This retrospective cohort study evaluated 920 overweight or obese Chinese adults aged 40 to 80 years free of cardiovascular disease at basel…
Overweight adults face higher heart risks than weight alone suggests since new measures combining body shape and blood sugar offer better cl…
Frontiers
Apr 29, 2026
Drug Pipeline
Sys. Review
PRISMA Scoping Review Examines Food-Drug Interactions in Cardiovascular and Diabetic Medications
Meals May Not Matter for Most New Heart and Diabetes Pills
This PRISMA scoping review synthesized data from 36 publications regarding food-drug interactions in cardiovascular and diabetic medications…
Most new heart and diabetes pills work the same whether you take them with food or on an empty stomach, but a few still need timing.
Frontiers
Apr 27, 2026
Diabetes & Endocrinology
Cohort
Cumulative LDL-C exposure strongly influences cardiovascular risk more than later-life levels
Lowering Cholesterol Earlier Cuts Heart Risk for Good
This perspective article discusses cardiovascular disease and familial hypercholesterolaemia. It states that cardiovascular risk is strongly…
Heart damage from high cholesterol builds slowly over decades, meaning waiting until middle age to act may already miss the best chance to p…
Frontiers
Apr 27, 2026
Drug Pipeline
Sys. Review
Narrative review supports SGLT-2i use in cardiovascular-kidney-metabolic syndrome
New Treatment Shifts How We Fight Heart, Kidney, and Diabetes Damage
This narrative review summarizes evidence on SGLT-2 inhibitors for patients with stages 2–4 cardiovascular-kidney-metabolic syndrome. The au…
Maria, 58, has type 2 diabetes and high blood pressure.
Frontiers
Apr 24, 2026
Drug Pipeline
Meta-analysis
Systematic review synthesizes Rhaponticum species chemistry, traditional uses, and research gaps across multiple conditions.
Ancient Herbs May Help Modern Health
This systematic review synthesizes data on Rhaponticum species, covering 24 documented species worldwide and their applications for conditio…
Imagine walking through a garden filled with wildflowers.
Frontiers
Apr 24, 2026
Drug Pipeline
Review of BRIDGE model for predicting lipid-lowering therapy adherence trajectories
New tool predicts why patients stop heart meds and how to fix it
This review summarizes a barrier-informed Bayesian model (BRIDGE) designed to predict adherence trajectories for lipid-lowering therapy in p…
A new computer model predicts why patients stop taking heart medicine and helps doctors fix the problem before it happens.
medRxiv
Apr 24, 2026
Diabetes & Endocrinology
Cohort
Higher Plasma Aldosterone Linked to 51% Increased CVD Risk in Hypertensive Patients
High aldosterone levels raise heart attack and stroke risk in patients with high blood pressure.
A cohort study of 8653 hypertensive patients found that higher plasma aldosterone concentration (PAC) was associated with a 51% increased ri…
Patients with high blood pressure and elevated aldosterone had a 51% higher risk of heart disease over five years.
Frontiers
Apr 23, 2026
Diabetes & Endocrinology
Phase III
Tirzepatide MTD Demonstrates Cost-Effectiveness Versus Semaglutide MTD in Obesity Simulation Modeling Study
Tirzepatide Saves Money and Health Over Semaglutide
This simulation modeling study using Phase-3 trial data evaluated tirzepatide versus semaglutide in individuals with obesity or overweight w…
Imagine standing in a doctor's office, facing a choice between two powerful weight-loss medicines.
Apr 22, 2026
Drug Pipeline
Cohort
Review of ginsenoside CK shows potential antiplatelet, anti-inflammatory, and cardioprotective effects in cardiovascular disease models.
This Natural Compound Could Shield Hearts and Prevent Strokes
This review evaluated ginsenoside CK and protopanaxadiol type ginsenosides regarding cardiovascular conditions. The analysis demonstrated an…
A specific compound from ginseng shows strong promise for protecting against heart disease and stroke.
Frontiers
Apr 22, 2026